Follow the Company on its website, LinkedIn, or X. The Ocular Therapeutix logo and DEXTENZA® are registered trademarks of Ocular Therapeutix, Inc. AXPAXLITM, PAXTRAVATM, ELUTYXTM, and Ocular ...
Prevent Blindness, the nation's leading nonprofit eye health organization, is announcing Dec. 2-8, 2024, as its fourth annual Geographic Atrophy (GA) Awareness Week. GA is an advanced form of dry ...
Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including ...
Opthea Limited Sponsored ADR (OPT) has released an update. Don't Miss our Black Friday Offers: Opthea Limited is set to showcase its promising treatment for wet age-related macular degeneration, ...
Dramatic 95% Reduction of Cognitive Decline in CT1812-treated Patients with Lower Plasma p-tau217 Correlated with Improvements in Key Indicators of ...